Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mitigating sTNF/TNFR1 activation on VGluT2+ spinal cord interneurons improves immune function after mid-thoracic spinal cord injury.
Martynyuk T, Ricard J, Bracchi-Ricard V, Price S, McGrath J, Dougherty K, Tom V, Bethea JR. Martynyuk T, et al. bioRxiv [Preprint]. 2024 Jul 13:2024.07.09.602690. doi: 10.1101/2024.07.09.602690. bioRxiv. 2024. Update in: Brain Behav Immun. 2025 Jan;123:633-643. doi: 10.1016/j.bbi.2024.10.021 PMID: 39026822 Free PMC article. Updated. Preprint.
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Ghofrani HA, Simonneau G, D'Armini AM, Fedullo P, Howard LS, Jaïs X, Jenkins DP, Jing ZC, Madani MM, Martin N, Mayer E, Papadakis K, Richard D, Kim NH; MERIT study investigators. Ghofrani HA, et al. Lancet Respir Med. 2024 Apr;12(4):e21-e30. doi: 10.1016/S2213-2600(24)00027-4. Lancet Respir Med. 2024. PMID: 38548406 Clinical Trial.
Diagnosis and Treatment Patterns of Chronic Thromboembolic Pulmonary Hypertension in Russia, Kazakhstan, Turkey, Lebanon, and Saudi Arabia: A Registry Study.
Öngen HG, Akdeniz B, Düzenli MA, Chernyavsky A, Dabar G, Idrees M, Khludeeva E, Kültürsay H, Lukianchikova V, Martynyuk T, Moğulkoç N, Mukarov MA, Mutlu B, Okumuş G, Omarov A, Önen ZP, Sakkijha H, Shostak N, Simakova M, Tokgözoğlu L, Tomskaya T, Yildirim H, Zateyshchikov D, Hechenbichler K, Kessner S, Schauerte I, Turgut N, Vogtländer K, Aldalaan A; CTEPH EMEA Registry Investigators. Öngen HG, et al. Among authors: martynyuk t. Drugs Real World Outcomes. 2024 Mar;11(1):149-165. doi: 10.1007/s40801-023-00407-w. Epub 2024 Feb 21. Drugs Real World Outcomes. 2024. PMID: 38381283 Free PMC article.
Increased activity of IRE1 improves the clinical presentation of EAE.
Bracchi-Ricard V, Nguyen K, Ricci D, Gaudette B, Henao-Mejia J, Brambilla R, Martynyuk T, Gidalevitz T, Allman D, Bethea JR, Argon Y. Bracchi-Ricard V, et al. Among authors: martynyuk t. FASEB J. 2023 Dec;37(12):e23283. doi: 10.1096/fj.202300769RR. FASEB J. 2023. PMID: 37983957 Free PMC article.
Increased activity of IRE1 improves the clinical presentation of EAE.
Bracchi-Ricard V, Nguyen K, Ricci D, Gaudette B, Henao-Meija J, Brambilla R, Martynyuk T, Gidalevitz T, Allman D, Bethea JR, Argon Y. Bracchi-Ricard V, et al. Among authors: martynyuk t. bioRxiv [Preprint]. 2023 Apr 20:2023.04.19.537391. doi: 10.1101/2023.04.19.537391. bioRxiv. 2023. Update in: FASEB J. 2023 Dec;37(12):e23283. doi: 10.1096/fj.202300769RR PMID: 37131811 Free PMC article. Updated. Preprint.
53 results